Bankert RB - Search Results

1

In vivo cytokine gene therapy of human tumor xenografts in SCID mice by liposome-mediated DNA delivery.

Egilmez NK, Cuenca R, Yokota SJ, Sorgi F, Bankert RB. Egilmez NK, et al. Among authors: bankert rb. Gene Ther. 1996 Jul;3(7):607-14. Gene Ther. 1996. PMID: 8818648

2

Liposome-mediated cytokine gene delivery to human tumor xenografts.

Eğilmez NK, Bankert RB. Eğilmez NK, et al. Among authors: bankert rb. Methods Enzymol. 2003;373:529-35. doi: 10.1016/S0076-6879(03)73033-X. Methods Enzymol. 2003. PMID: 14714425 No abstract available.

3

Antitumor immune response of human peripheral blood lymphocytes coengrafted with tumor into severe combined immunodeficient mice.

Iwanuma Y, Chen FA, Egilmez NK, Takita H, Bankert RB. Iwanuma Y, et al. Among authors: bankert rb. Cancer Res. 1997 Jul 15;57(14):2937-42. Cancer Res. 1997. PMID: 9230205

4

Cytokine immunotherapy of cancer with controlled release biodegradable microspheres in a human tumor xenograft/SCID mouse model.

Egilmez NK, Jong YS, Iwanuma Y, Jacob JS, Santos CA, Chen FA, Mathiowitz E, Bankert RB. Egilmez NK, et al. Among authors: bankert rb. Cancer Immunol Immunother. 1998 Mar;46(1):21-4. doi: 10.1007/s002620050455. Cancer Immunol Immunother. 1998. PMID: 9520288 Free PMC article.

5

Growth of human tumor xenografts in SCID mice quantified using an immunoassay for tumor marker protein in serum.

Conway TF Jr, Sabel MS, Sugano M, Frelinger JG, Egilmez NK, Chen F, Bankert RB. Conway TF Jr, et al. Among authors: bankert rb. J Immunol Methods. 2000 Jan 13;233(1-2):57-65. doi: 10.1016/s0022-1759(99)00190-8. J Immunol Methods. 2000. PMID: 10648856

6

Cytokines delivered by biodegradable microspheres promote effective suppression of human tumors by human peripheral blood lymphocytes in the SCID-Winn model.

Egilmez NK, Jong YS, Hess SD, Jacob JS, Mathiowitz E, Bankert RB. Egilmez NK, et al. Among authors: bankert rb. J Immunother. 2000 Mar-Apr;23(2):190-5. doi: 10.1097/00002371-200003000-00003. J Immunother. 2000. PMID: 10746545

7

Antibody targeting of doxorubicin-loaded liposomes suppresses the growth and metastatic spread of established human lung tumor xenografts in severe combined immunodeficient mice.

Sugano M, Egilmez NK, Yokota SJ, Chen FA, Harding J, Huang SK, Bankert RB. Sugano M, et al. Among authors: bankert rb. Cancer Res. 2000 Dec 15;60(24):6942-9. Cancer Res. 2000. PMID: 11156394

8

Human inflammatory cells within the tumor microenvironment of lung tumor xenografts mediate tumor growth suppression in situ that depends on and is augmented by interleukin-12.

Sugiyama Y, Kato M, Chen FA, Williams SS, Kawaguchi Y, Miya K, Jong YS, Mathiowitz E, Egilmez NK, Bankert RB. Sugiyama Y, et al. Among authors: bankert rb. J Immunother. 2001 Jan-Feb;24(1):37-45. doi: 10.1097/00002371-200101000-00005. J Immunother. 2001. PMID: 11211147

9

Human-SCID mouse chimeric models for the evaluation of anti-cancer therapies.

Bankert RB, Egilmez NK, Hess SD. Bankert RB, et al. Trends Immunol. 2001 Jul;22(7):386-93. doi: 10.1016/s1471-4906(01)01943-3. Trends Immunol. 2001. PMID: 11429323 Review.

10

Antitumor efficacy of a human interleukin-12 expression plasmid demonstrated in a human peripheral blood leukocyte/human lung tumor xenograft SCID mouse model.

Hess SD, Egilmez NK, Shiroko J, Bankert RB. Hess SD, et al. Among authors: bankert rb. Cancer Gene Ther. 2001 May;8(5):371-7. doi: 10.1038/sj.cgt.7700314. Cancer Gene Ther. 2001. PMID: 11477457

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

141 results

Search Page

Filters